Geron Stock Price (NASDAQ:GERN)

Add to My Stocks
$3.48 $0.11 (3.06%) GERN stock closing price Jul 19, 2018 (Closing)
Prev Close* : $3.59
Market Cap:
$621.36M
Day Low: $3.36
52 Week Low: $1.74
Open: $3.59
Volume: -
Day High: $3.6
52 Week High: $6.68
Dividend:
0.00

Latest Stock Market News

Latest Articles

Geron News - From Partners

GERN Stockcharts

View GERN PE ratio, PS ratio stocks charts and compare with peers.
GERN Chart
Note: Compare Geron stock price history with the index and industry peers.

Geron Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
686.07
PB ratio (
price to book ratio
)
5.3

Geron Returns

ROE
(return on equity)
-26%

Geron Financial Ratios

Asset Turnover
0.01
Receivables Turnover
1.65
Debt to Equity
0
Dividend Yield
0%

GERN Industry Peers

Company Price Change (%)
Eloxx Pharmact (ELOX)17.410.21 (1.19%)
Fate Therapeutics (FATE)11.030.66 (5.65%)
Baxalta (BXLT)46.020.18 (0.39%)
Onconova Therapeutics (ONTX)0.480.01 (2.13%)
Cti Biopharma (CTIC)2.261.73 (43.36%)
Stemline Therapeutics (STML)16.10 (0%)
Gilead Sciences (GILD)77.120.08 (0.1%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Retrophin (RTRX)31.61.55 (5.16%)
Xoma (XOMA)24.10.97 (4.19%)
Compugen (CGEN)3.350.1 (3.08%)
Alnylam Pharma (ALNY)105.373.1 (3.03%)
Prothena (PRTA)14.770.39 (2.71%)
Momenta Pharma (MNTA)29.40.75 (2.62%)
MiMedx (MDXG)3.410.08 (2.4%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 19, 2018
CompanyPriceChange (%)
AVEO Pharmaceuticals (AVEO)1.950.21 (9.72%)
Cara Therapeutics (CARA)19.821.78 (8.24%)
Fate Therapeutics (FATE)11.030.66 (5.65%)
Uniquire (QURE)34.871.72 (4.7%)
Catalyst Biosciences (CBIO)11.610.53 (4.37%)
Idera Pharma (IDRA)0.9380.04 (4.1%)
Fortress Biotech (FBIO)2.690.11 (3.93%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 19, 2018

Geron Corporation Stock News - Partner Headlines

Geron Financial Statements

income statement20172016201520142013
Net Sales or Revenues1.06M6.16M36.37M1.15M1.28M
Net Income-27.91M-29.53M--35.67M-38.37M
Total Operating Expense30.31M36.8M36.92M37.45M40.23M
View Geron income statement
balance sheet20172016201520142013
Total Assets110.31M130.24M148.76M172.51M67.34M
Total Liabilities6.51M7.86M6.63M41.79M7.58M
Shareholders Equity103.79M122.38M142.12M130.71M59.75M
View Geron balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-1.37M2.08M-35.3M34.41M-4.77M
Net Cash from (used by) Operating Activities-20.55M-18.36M-24.19M9.35M-36.68M
Increase (Decrease) in Prop Plant And Equipment--0.04M-0.09M-0.13M1.19M
View Geron cash flow statement

Geron Stock Message Board

An investor needs to spend $3.48 to buy GERN stock, as the closing Geron stock price is $3.48. Looking at Geron market capitalization, which currently stands at $621.36M, we can say that GERN stock is a Small Cap stock. Geron valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Geron stock price and Geron share price mean the same thing. 5,923,377 shares were traded with a closing stock price of $3.48 as of Jul 19, 2018, as can be seen from Geron stock quote. One can view Geron stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Geron dividend per share was 0.00 during the last quarter. Geron stock price history, gives the entire historical data for GERN stock.